The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer
- 13 June 2007
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 133 (10) , 787-791
Abstract
Based on the well-established role of vascular endothelial growth factor (VEGF) in tumor-associated angiogenesis in several cancer types and its undefined role in oral oncogenesis, we investigated the possible association of an expression-regulating polymorphism (+936C/T) with risk for oral squamous cell carcinoma (OSCC). We studied the allele frequencies of the +936C/T polymorphism in DNA samples of 144 patients with OSCC and 153 healthy controls matched by age, gender and ethnicity, using restriction fragment length polymorphism typing analysis. The low-expression T allele was significantly increased in the total patient group compared to controls (P = 0.008), due to a significant over-representation of C/T heterozygotes compared to C/C homozygotes (P = 0.007). The same pattern was observed in most patient subgroups and more noticeably in patients with a positive family history of cancer (P = 0.001). Interestingly, the increase in T allele frequency was only significant in patients at cancer stages I and II (P = 0.006). This study clearly indicates that the low-VEGF-production T allele is strongly associated with increased risk for OSCC. In addition, the impressive T allele frequency increment in patients with a positive family cancer history suggests that this allele may also be involved in other malignancies. The fact that this significant increase was observed only in patients with early cancer stages may imply that low VEGF levels might hinder subsequent tumorigenesis. Our findings might be the result of either unidentified properties of the +936 C/T polymorphism or of a strong linkage disequilibrium between this polymorphism and another genetic locus.Keywords
This publication has 28 references indexed in Scilit:
- The interleukin-8 (−251A/T) polymorphism is associated with increased risk for oral squamous cell carcinomaEuropean Journal of Surgical Oncology, 2007
- Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survivalJournal of Surgical Oncology, 2006
- Vascular endothelial growth factor C936T polymorphism in cancer patients with thrombosisAmerican Journal of Hematology, 2006
- Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcomeCytokine, 2006
- Population-Based Case-Control Study of VEGF Gene Polymorphisms and Breast Cancer Risk among Chinese WomenCancer Epidemiology, Biomarkers & Prevention, 2006
- Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancerEuropean Journal of Surgical Oncology, 2006
- The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinomaOral Oncology, 2006
- Association of Genetic Polymorphisms in the VEGF Gene with Breast Cancer SurvivalCancer Research, 2005
- Association of VEGF genotype with mRNA level in colorectal adenocarcinomasBiochemical and Biophysical Research Communications, 2004
- Single Nucleotide Polymorphisms in the 3' Untranslated Region of Vascular Endothelial Growth Factor Gene in Japanese Population with or without Renal Cell Carcinoma.The Tohoku Journal of Experimental Medicine, 2002